Afyx Therapeutics A/S — Credit Rating and Financial Key Figures

Afyx Therapeutics A/S (CVR number: 38793594) is a company from RUDERSDAL. The company recorded a gross profit of 6405 kDKK in 2023. The operating profit was -4355.7 kDKK, while net earnings were -2253.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was -30.6 %, which can be considered poor and Return on Equity (ROE) was -26.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 30 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Afyx Therapeutics A/S's liquidity measured by quick ratio was 1.3 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.